Ardelyx Announces Positive Topline Results from Pivotal Phase 3

ARDX: Ardelyx
2019-12-03 07:25:00
Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis